Corcept Therapeutics Inc. (CORT) on GreekSoup https://greeksoup.ai/stocks/us/cort/ Every dated entry in the public record on Corcept Therapeutics Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Fri, 09 Oct 2026 00:00:00 +0000 Corcept Therapeutics Inc.: Vieira Roberto Wandenkolk (President, Oncology) sold 1,100 shares at $114.52 on 2 October 2026, $125,973https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-10-05:4ee60dbfe0Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Vieira Roberto Wandenkolk (President, Oncology) sold 2,086 shares at $115.73 on 2 October 2026, $241,412https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-10-05:acf6feaeebMon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Vieira Roberto Wandenkolk (President, Oncology) sold 5,147 shares at $116.58 on 2 October 2026, $600,063https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-10-05:46049e4fd5Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Lyon Joseph Douglas (See Remarks) sold 4,446 shares at $115.70 on 2 October 2026, $514,389https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-10-05:5a2908a842Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Lyon Joseph Douglas (See Remarks) sold 4,744 shares at $116.54 on 2 October 2026, $552,869https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-10-05:3f345f17f8Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Maduck Sean (See Remarks) sold 15,843 shares at $116.12 on 2 October 2026, $1.8 millionhttps://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-10-05:782dc9975aMon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Maduck Sean (See Remarks) sold 8,744 shares at $116.55 on 2 October 2026, $1.0 millionhttps://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-10-05:34feada56fMon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Lyon Joseph Douglas (See Remarks) sold 810 shares at $115.40 on 1 October 2026, $93,473https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-10-05:fe9354cc3dMon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Maduck Sean (See Remarks) sold 413 shares at $115.54 on 1 October 2026, $47,717https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-10-05:2b9e98a721Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Form 144, Lyon Joseph Douglas plans to sell 10,000 shares worth $1.2 million around 1 October 2026https://greeksoup.ai/stocks/us/cort/planned-sales/us:CORT:planned-sale:2026-10-01:3946f532daThu, 01 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc. filed 8-K: officer or director change, regulation fd disclosurehttps://greeksoup.ai/stocks/us/cort/filings/us:CORT:filing:2026-09-23:0c64955da4Wed, 23 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Vieira Roberto Wandenkolk (President, Oncology) sold 296 shares at $100.82 on 16 September 2026, $29,843https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-09-18:1f010c7aaeFri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Wilson James N (Director) sold 6,800 shares at $110.27 on 15 September 2026, $749,835https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-09-16:785decb82bWed, 16 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Wilson James N (Director) sold 400 shares at $110.84 on 15 September 2026, $44,335https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-09-16:ca28791a30Wed, 16 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Wilson James N (Director) sold 2,800 shares at $111.70 on 15 September 2026, $312,771https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-09-16:6547bee321Wed, 16 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Lyon Joseph Douglas (See Remarks) sold 7,812 shares at $113.32 on 14 September 2026, $885,261https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-09-16:01eac64714Wed, 16 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Lyon Joseph Douglas (See Remarks) sold 2,188 shares at $114.12 on 14 September 2026, $249,686https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-09-16:9cc84a0138Wed, 16 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Form 144, WILSON JAMES N plans to sell 30,000 shares worth $3.3 million around 15 September 2026https://greeksoup.ai/stocks/us/cort/planned-sales/us:CORT:planned-sale:2026-09-15:e56ace08d4Tue, 15 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: short interest 9,350,914 shares at the 15 September 2026 settlement, 9.91 days to coverhttps://greeksoup.ai/stocks/us/cort/short-interest/us:CORT:short-interest:2026-09-15:a4706a193dTue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Form 144, Lyon Joseph Douglas plans to sell 10,000 shares worth $1.1 million around 14 September 2026https://greeksoup.ai/stocks/us/cort/planned-sales/us:CORT:planned-sale:2026-09-14:25f0527a9dMon, 14 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Vieira Roberto Wandenkolk (President, Oncology) sold 23,600 shares at $109.35 on 2 September 2026, $2.6 millionhttps://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-09-03:eff9ab1069Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Vieira Roberto Wandenkolk (President, Oncology) sold 23,770 shares at $110.70 on 2 September 2026, $2.6 millionhttps://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-09-03:cf74573c9eThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Vieira Roberto Wandenkolk (President, Oncology) sold 1,537 shares at $111.37 on 2 September 2026, $171,181https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-09-03:5da58be81fThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Vieira Roberto Wandenkolk (President, Oncology) sold 974 shares at $112.40 on 2 September 2026, $109,474https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-09-03:aaadd77116Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Vieira Roberto Wandenkolk (President, Oncology) sold 1,606 shares at $113.72 on 2 September 2026, $182,632https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-09-03:109a274169Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Vieira Roberto Wandenkolk (President, Oncology) sold 5,621 shares at $114.58 on 2 September 2026, $644,042https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-09-03:67e2b49b24Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Vieira Roberto Wandenkolk (President, Oncology) sold 1,225 shares at $115.44 on 2 September 2026, $141,413https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-09-03:378136d82bThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Maduck Sean (See Remarks) sold 11,730 shares at $113.94 on 1 September 2026, $1.3 millionhttps://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-09-03:b76376fafdThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Maduck Sean (See Remarks) sold 10,989 shares at $114.71 on 1 September 2026, $1.3 millionhttps://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-09-03:06301f6075Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Maduck Sean (See Remarks) sold 2,281 shares at $115.61 on 1 September 2026, $263,711https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-09-03:af8d0c9db3Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Form 144, Vieira Roberto Wandenkolk plans to sell 75,295 shares worth $8.3 million around 2 September 2026https://greeksoup.ai/stocks/us/cort/planned-sales/us:CORT:planned-sale:2026-09-02:9844a14871Wed, 02 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: short interest 9,399,154 shares at the 31 August 2026 settlement, 11.90 days to coverhttps://greeksoup.ai/stocks/us/cort/short-interest/us:CORT:short-interest:2026-08-31:94a71dfd04Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Park Kimberly (Director) sold 26,685 shares at $122.55 on 26 August 2026, $3.3 millionhttps://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-28:8ac0ecad60Fri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Maduck Sean (See Remarks) sold 25,085 shares at $125.47 on 25 August 2026, $3.1 millionhttps://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-27:718142f730Thu, 27 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Maduck Sean (See Remarks) sold 5,870 shares at $126.06 on 25 August 2026, $739,965https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-27:660e3b05c9Thu, 27 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Form 144, KIMBERLY PARK plans to sell 26,685 shares worth $3.3 million around 26 August 2026https://greeksoup.ai/stocks/us/cort/planned-sales/us:CORT:planned-sale:2026-08-26:4c73490ca8Wed, 26 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Form 144, Maduck Sean plans to sell 175,000 shares worth $22.0 million around 25 August 2026https://greeksoup.ai/stocks/us/cort/planned-sales/us:CORT:planned-sale:2026-08-25:51692202f2Tue, 25 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Mahoney David L (Director) sold 4,984 shares at $117.47 on 18 August 2026, $585,478https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-20:84955fd8eaThu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Mahoney David L (Director) sold 91,167 shares at $118.24 on 18 August 2026, $10.8 millionhttps://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-20:dbbba36075Thu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Mahoney David L (Director) sold 7,055 shares at $118.88 on 18 August 2026, $838,710https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-20:37a80f2c86Thu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Mahoney David L (Director) sold 400 shares at $119.64 on 18 August 2026, $47,855https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-20:085d77edcaThu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Form 144, MAHONEY DAVID L plans to sell 103,606 shares worth $12.2 million around 18 August 2026https://greeksoup.ai/stocks/us/cort/planned-sales/us:CORT:planned-sale:2026-08-18:370cfa604cTue, 18 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Robb Gary Charles (Chief Business Officer) sold 10,000 shares at $116.26 on 17 August 2026, $1.2 millionhttps://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-18:8cee9e69e3Tue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Maduck Sean (See Remarks) sold 3,664 shares at $114.49 on 14 August 2026, $419,491https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-18:2c916f708dTue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Wilson James N (Director) sold 3,053 shares at $110.49 on 14 August 2026, $337,341https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-18:bd9b164c87Tue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Wilson James N (Director) sold 4,668 shares at $111.44 on 14 August 2026, $520,214https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-18:166f50d01fTue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Wilson James N (Director) sold 2,279 shares at $112.64 on 14 August 2026, $256,706https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-18:ca3afb6755Tue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Form 144, Robb Gary Charles plans to sell 10,000 shares worth $1.2 million around 17 August 2026https://greeksoup.ai/stocks/us/cort/planned-sales/us:CORT:planned-sale:2026-08-17:7da57ef592Mon, 17 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: short interest 9,696,757 shares at the 14 August 2026 settlement, 10.45 days to coverhttps://greeksoup.ai/stocks/us/cort/short-interest/us:CORT:short-interest:2026-08-14:7fc312906aFri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Schedule 13G/A filed by Renaissance Technologies LLC, 4.9% of the classhttps://greeksoup.ai/stocks/us/cort/holders/us:CORT:schedule-13:2026-08-13:f5c01d7610Thu, 13 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Maduck Sean (See Remarks) sold 1,031 shares at $114.52 on 10 August 2026, $118,068https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-12:f5340273b1Wed, 12 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Guyer William (Chief Development Officer) sold 11,530 shares at $113.18 on 10 August 2026, $1.3 millionhttps://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-12:9eff66f10aWed, 12 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Guyer William (Chief Development Officer) sold 4,770 shares at $114.04 on 10 August 2026, $543,957https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-12:ebb48a395cWed, 12 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Guyer William (Chief Development Officer) sold 3,700 shares at $113.12 on 4 August 2026, $418,562https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-06:1e315a2097Thu, 06 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Maduck Sean (See Remarks) sold 20,305 shares at $114.70 on 3 August 2026, $2.3 millionhttps://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-05:bc793415cfWed, 05 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Lyon Joseph Douglas (See Remarks) sold 1,540 shares at $114.16 on 3 August 2026, $175,806https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-05:feab8095ddWed, 05 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Form 144, Guyer William plans to sell 20,000 shares worth $2.3 million around 4 August 2026https://greeksoup.ai/stocks/us/cort/planned-sales/us:CORT:planned-sale:2026-08-04:4c2a7940daTue, 04 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Form 144, Lyon Joseph Douglas plans to sell 1,540 shares worth $175,806 around 3 August 2026https://greeksoup.ai/stocks/us/cort/planned-sales/us:CORT:planned-sale:2026-08-03:9ee6052002Mon, 03 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Mokari Atabak (Chief Financial Officer) sold 4,200 shares at $105.54 on 30 July 2026, $443,248https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-03:aafdc98700Mon, 03 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Mokari Atabak (Chief Financial Officer) sold 8,956 shares at $106.96 on 30 July 2026, $957,892https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-03:29a67eeac5Mon, 03 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Mokari Atabak (Chief Financial Officer) sold 400 shares at $108.46 on 30 July 2026, $43,384https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-03:e5df4789abMon, 03 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Mokari Atabak (Chief Financial Officer) sold 2,202 shares at $110.03 on 30 July 2026, $242,282https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-03:b9780569e9Mon, 03 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Mokari Atabak (Chief Financial Officer) sold 600 shares at $110.95 on 30 July 2026, $66,570https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-03:2ced57e586Mon, 03 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Mokari Atabak (Chief Financial Officer) sold 4,700 shares at $113.18 on 30 July 2026, $531,941https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-03:c36f0c0e2dMon, 03 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Mokari Atabak (Chief Financial Officer) sold 15,477 shares at $114.96 on 30 July 2026, $1.8 millionhttps://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-03:f9ab007ee8Mon, 03 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Mokari Atabak (Chief Financial Officer) sold 14,222 shares at $115.87 on 30 July 2026, $1.6 millionhttps://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-03:dc2551b9deMon, 03 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Mokari Atabak (Chief Financial Officer) sold 7,089 shares at $116.96 on 30 July 2026, $829,102https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-03:0e55ca39b5Mon, 03 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Mokari Atabak (Chief Financial Officer) sold 8,267 shares at $117.93 on 30 July 2026, $974,951https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-03:2d06230e23Mon, 03 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Mokari Atabak (Chief Financial Officer) sold 4,783 shares at $118.73 on 30 July 2026, $567,908https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-03:9dafd0bdbbMon, 03 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Mokari Atabak (Chief Financial Officer) sold 8,103 shares at $119.95 on 30 July 2026, $971,939https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-03:0025c48933Mon, 03 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Mokari Atabak (Chief Financial Officer) sold 1,001 shares at $120.67 on 30 July 2026, $120,796https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-08-03:73e9b8f8cbMon, 03 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: short interest 9,819,732 shares at the 31 July 2026 settlement, 6.38 days to coverhttps://greeksoup.ai/stocks/us/cort/short-interest/us:CORT:short-interest:2026-07-31:5d076cf0e5Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Form 144, Mokari Atabak plans to sell 40,000 shares worth $4.6 million around 30 July 2026https://greeksoup.ai/stocks/us/cort/planned-sales/us:CORT:planned-sale:2026-07-30:7b505e80c7Thu, 30 Jul 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc. Q2 FY2026 results: revenue $256 million, net income $43 millionhttps://greeksoup.ai/stocks/us/cort/results/fy2026-q2/us:CORT:result:2026-07-29:96243ae707Wed, 29 Jul 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/cort/filings/us:CORT:filing:2026-07-29:9756c4c6abWed, 29 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc. filed 8-K: results of operations, regulation fd disclosurehttps://greeksoup.ai/stocks/us/cort/filings/us:CORT:filing:2026-07-29:d867e73d94Wed, 29 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Wilson James N (Director) sold 1,079 shares at $86.78 on 15 July 2026, $93,633https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-07-17:7027c5b9bcFri, 17 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Wilson James N (Director) sold 3,969 shares at $87.74 on 15 July 2026, $348,223https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-07-17:bf965e41bbFri, 17 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Wilson James N (Director) sold 2,974 shares at $88.81 on 15 July 2026, $264,122https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-07-17:a6aa97652bFri, 17 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Wilson James N (Director) sold 1,978 shares at $89.49 on 15 July 2026, $177,007https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-07-17:bfc8a40d24Fri, 17 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Mokari Atabak (Chief Financial Officer) sold 7,919 shares at $86.78 on 15 July 2026, $687,179https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-07-17:5fe251d769Fri, 17 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Mokari Atabak (Chief Financial Officer) sold 28,460 shares at $87.89 on 15 July 2026, $2.5 millionhttps://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-07-17:b5620a5115Fri, 17 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Mokari Atabak (Chief Financial Officer) sold 3,520 shares at $88.30 on 15 July 2026, $310,822https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-07-17:892e222c33Fri, 17 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: Mokari Atabak (Chief Financial Officer) sold 101 shares at $89.43 on 15 July 2026, $9,032https://greeksoup.ai/stocks/us/cort/insiders/us:CORT:insider:2026-07-17:2b676e5266Fri, 17 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Corcept Therapeutics Inc.: short interest 9,442,750 shares at the 15 July 2026 settlement, 8.69 days to coverhttps://greeksoup.ai/stocks/us/cort/short-interest/us:CORT:short-interest:2026-07-15:cb1626576fWed, 15 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>